Showing results (61-70 of 283) with videos related to
Sort By:
Pageof 29
Circulation. Cardiovascular Interventions|May 5, 2026
Clinical Experience With a Novel Percutaneous LV Assist Device in High-Risk PCI: Primary Results From the SUPPORT I StudyDavid E Kandzari, Andrea Mignatti, Annapoorna Kini, et al.Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|September 2, 2022
Sirolimus-coated balloon versus everolimus-eluting stent in de novo coronary artery disease: Rationale and design of the TRANSFORM II randomized clinical trialAntonio Greco, Alessandro Sciahbasi, Alexandre Abizaid, et al.Arquivos Brasileiros De Cardiologia|October 24, 2009
Percutaneous aortic valve replacement for the treatment of aortic stenosis: early experience in BrazilMarco Antonio Perin, Fábio Sândoli de Brito, Breno Oliveira Almeida, et al.Cardiovascular Intervention and Therapeutics|October 9, 2015
Feasibility of 320-row multi-detector computed tomography angiography to assess bioabsorbable everolimus-eluting vascular scaffoldsMasahiko Asami, Jiro Aoki, Patrick W Serruys, et al.Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|February 21, 2020
Long-term serial functional evaluation after implantation of the Fantom sirolimus-eluting bioresorbable coronary scaffoldYuichi Saito, Ecaterina Cristea, Georgios Bouras, et al.Journal of Interventional Cardiology|February 22, 2012
One-year clinical outcomes after sirolimus-eluting coronary stent implantation for acute myocardial infarction in the worldwide e-SELECT registryStephen G Worthley, Alexandre Abizaid, Adrian Banning, et al.Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|October 15, 2015
DESyne novolimus-eluting coronary stent is superior to Endeavor zotarolimus-eluting coronary stent at five-year follow-up: final results of the multicentre EXCELLA II randomised controlled trialJavaid Iqbal, Stefan Verheye, Alexandre Abizaid, et al.Journal of Interventional Cardiology|December 18, 2012
One-year outcome of small-vessel disease treated with sirolimus-eluting stents: a subgroup analysis of the e-SELECT registryRunlin Gao, Alexandre Abizaid, Adrian Banning, et al.JACC. Cardiovascular Interventions|January 15, 2016
Polymer-Free Biolimus A9-Coated Stents in the Treatment of De Novo Coronary Lesions: 4- and 12-Month Angiographic Follow-Up and Final 5-Year Clinical Outcomes of the Prospective, Multicenter BioFreedom FIM Clinical TrialRicardo A Costa, Alexandre Abizaid, Roxana Mehran, et al.Revista Portuguesa De Cardiologia|January 21, 2018
CKD-EPI versus Cockcroft-Gault formula for predicting contrast-induced nephropathy following percutaneous coronary intervention in patients without significant renal impairmentMário B G Nunes, Antônio C Filho, Valéria R C Alvares, et al.Pageof 29